Lv5
910 积分 2026-03-16 加入
DMPK Considerations for the Development of Covalent Drugs: Insights from an IQ Assessment
2小时前
已完结
TMDD Modeling for Antibodies Directed Against Soluble Targets: Parameter Values for De Novo Modeling and Simulation From Experimental Data
1个月前
已完结
Double Peaking Phenomena in Pharmacokinetic Disposition Revisited
1个月前
已完结
Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing?
1个月前
已完结
Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial
1个月前
已完结
Dose-Response Relationship of GLP-1 Receptor Agonists on HbA1c and Body Weight in Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis
1个月前
已完结
Optimal use of once weekly icodec insulin in type-2 diabetes: An updated meta-analysis of phase-2 and phase-3 randomized controlled trials
1个月前
已完结
Evaluating semaglutide + LAI-287 (IcoSema) for the treatment of diabetes mellitus type II
1个月前
已完结
Free and fixed‐ratio combinations of basal insulin and GLP‐1 receptor agonists versus basal insulin intensification in type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials
1个月前
已完结
Once‑weekly IcoSema versus once‑weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open‑label, multicentre, treat‑to‑target, randomised, phase 3a trial
1个月前
已完结
皖公网安备34019202002308
